LRP1 and Alzheimer disease: For instance, as demonstrated in Alzheimer's disease (AD) mouse models, the brain endothelium exhibits significant dysregulation, including upregulated RAGE expression which leads to increased levels of amyloid-β (Aβ) peptides that compete with LRP1-targeting vectors for transcytosis (Israel 2022).